Glossary / Lexicon
Quazepam
Quazepam belongs to a class of drugs called benzodiazepines.
These drugs are used to ease Anxiety and slow the central nervous system. In the United States, Quazepam is sold under brand name Doral. It is approved by the United States Food and Drug Administration for the treatment of insomnia.
Related Articles | |
Anxiolytics at psychology-glossary.com | ■■■■■ |
Anxiolytics refers to the medications that reduce the symptoms of anxiety. Anxiolytics are prescription . . . Read More | |
Medication at psychology-glossary.com | ■■■■ |
Medication refers to: (1) A drug or medicine. (2) The administration of a drug or medicine In the psychology . . . Read More | |
Chemotherapy at top500.de | ■■■■ |
Chemotherapy is a medical treatment that involves the use of drugs to destroy cancer cells. In an industrial . . . Read More | |
Chlorambucil at top500.de | ■■■■ |
Chlorambucil in the industrial context refers to its production, handling, and application in the pharmaceutical . . . Read More | |
Alcohol at psychology-glossary.com | ■■■■ |
Alcohol is a central nervous system depressant. It is an ethanol produced by the action of yeast on sugars. . . . Read More | |
Stimulant drugs at psychology-glossary.com | ■■■■ |
Stimulant drugs refer to drugs that increase the activity of the central nervous system, providing a . . . Read More | |
Narcotic at psychology-glossary.com | ■■■■ |
Narcotic is defined as a central nervous system depressant that contains sedative and pain-relieving . . . Read More | |
Organic mental disorder at psychology-glossary.com | ■■■■ |
Organic mental disorder or OMD refers to a mental or emotional problem caused by brain diseases or injuries. . . . Read More | |
Psychoactive at psychology-glossary.com | ■■■■ |
Psychoactive means pertaining to effects on mood, thinking, and behavior Description In the psychology . . . Read More | |
Beta blockers at psychology-glossary.com | ■■■■ |
Beta blockers refers to a class of drugs typically used to decrease blood pressure and also prescribed . . . Read More |